Maximus (NYSE:MMS) Announces Quarterly Earnings Results, Beats Estimates By $0.26 EPS

Maximus (NYSE:MMS) issued its earnings results on Wednesday. The health services provider reported $1.57 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.26, Briefing.com reports. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 15.68% and a net margin of 3.73%. Maximus’s revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.80 EPS. Maximus updated its FY24 guidance to $5.65-5.85 EPS and its FY 2024 guidance to 5.650-5.850 EPS.

Maximus Stock Performance

Maximus stock traded down $0.35 during trading hours on Thursday, hitting $83.77. 311,321 shares of the stock traded hands, compared to its average volume of 324,665. Maximus has a 1 year low of $72.39 and a 1 year high of $90.65. The stock has a market capitalization of $5.11 billion, a price-to-earnings ratio of 28.75 and a beta of 0.72. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The firm’s 50 day moving average price is $82.34 and its 200-day moving average price is $81.63.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.43%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus’s payout ratio is 39.74%.

Insider Buying and Selling

In other Maximus news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the transaction, the chief financial officer now owns 5,124 shares in the company, valued at $430,159.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.40% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.